Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Mar 18, 2024 (filed on Mar 20, 2024)Insider Name:Clemens Jason AOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:128,380Price:--
-
Mar 12, 2024 (filed on Mar 12, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Class A Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-114,906Price:$10.70
-
Mar 11, 2024 (filed on Mar 12, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Class A Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-88,040Price:$11.13
-
Mar 11, 2024 (filed on Mar 12, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Class A Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-94,567Price:$10.92
-
Mar 08, 2024 (filed on Mar 12, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Class A Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-4,495Price:$11.03
-
Mar 08, 2024 (filed on Mar 12, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Class A Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-47,992Price:$10.92
-
Mar 08, 2024 (filed on Mar 08, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Private Placement WarrantsNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Mar 08, 2024 (filed on Mar 08, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Series B-1 Convertible Preferred StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Mar 08, 2024 (filed on Mar 08, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Series B-1 Convertible Preferred StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Mar 08, 2024 (filed on Mar 08, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Class A Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
Filings by filing date
-
Nov 18, 2022 (filed on Apr 08, 2024)Insider Name:Barasch Richard AOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:Form 5 : Annual Statement of Beneficial Ownership of Securities# or value acquired/disposed of:-10,000Price:--
-
Mar 18, 2024 (filed on Mar 20, 2024)Insider Name:Clemens Jason AOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:128,380Price:--
-
Mar 12, 2024 (filed on Mar 12, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Class A Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-114,906Price:$10.70
-
Mar 11, 2024 (filed on Mar 12, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Class A Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-88,040Price:$11.13
-
Mar 11, 2024 (filed on Mar 12, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Class A Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-94,567Price:$10.92
-
Mar 08, 2024 (filed on Mar 12, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Class A Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-4,495Price:$11.03
-
Mar 08, 2024 (filed on Mar 12, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Class A Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-47,992Price:$10.92
-
Mar 08, 2024 (filed on Mar 08, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Private Placement WarrantsNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Mar 08, 2024 (filed on Mar 08, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Series B-1 Convertible Preferred StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Mar 08, 2024 (filed on Mar 08, 2024)Insider Name:Flynn James EOwnership Type:Indirect OwnershipSecurities:Series B-1 Convertible Preferred StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 220 W Germantown Pike Ste 250 PLYMOUTH MEETING PA 19462 |
Tel: | N/A |
Website: | https://adapthealth.com/investor-relations |
IR: | See website |
Key People | ||
Richard A. Barasch Chairman of the Board, Interim Chief Executive Officer | Joshua Parnes President, Director | Jason A. Clemens Chief Financial Officer |
Shaw Rietkerk Chief Operating Officer | Albert Prast Chief Technology Officer | Christie Archbold Chief Accounting Officer |
Business Overview |
Adapthealth Corp. provides patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies and related services. The Company is primarily focused on providing sleep therapy equipment, supplies and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors (CGM) and insulin pumps; home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. It serves patients annually in all 50 states through its network of approximately 680 locations in 47 states. |
Financial Overview |
For the fiscal year ended 31 December 2023, Adapthealth Corp revenues increased 8% to $3.2B. Net loss applicable to common stockholders totaled $678.9M vs. income of $63.4M. Revenues reflect Insurance segment increase of 7% to $1.93B, Government segment increase of 9% to $852.8M. Net loss reflects General and administrative expenses increase of 19% to $144.6M (expense), Other loss (income). |
Employees: | 10,700 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $3,356M as of Dec 31, 2023 |
Annual revenue (TTM): | $3,200M as of Dec 31, 2023 |
EBITDA (TTM): | $621.63M as of Dec 31, 2023 |
Net annual income (TTM): | -$678.90M as of Dec 31, 2023 |
Free cash flow (TTM): | $143.20M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $2,103M as of Dec 31, 2023 |
Shares outstanding: | 132,907,103 as of Feb 23, 2024 |
Index Membership: | S&P 600 Small Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |